微量元素与健康研究杂志

期刊简介

               本刊是国内外公开发行的综合性学术刊物,创办于1984年。原名《微量元素》,1992年更名为《微量元素与健康研究》。是国内创刊最早的唯一一份微量元素学科专业期刊。现被“中国核心期刊(遴选)数据库”、“CNKI中国期刊全文数据库”全文收录,《中国期刊网》、《万方数据-数字化期刊群》入网期刊,《中国学术期刊(光盘版)》入编期刊,《中文生物医学期刊文献数据库》(CMCC)、《中文科技期刊数据库》、《中文科技资料目录—医药卫生》全文收录,并被列为《中国学术期刊综合评价数据库》来源期刊,《CAJ-CD规范》执行优秀期刊。    从2003年起,本刊已由原来的季刊改为双月刊,逢双月28日出刊。发表周期可由原来的6~9个月缩短至平均3~6个月或更短。为了节省审稿时间,编辑部承诺:①凡经编委推荐的具有突破性创新成果的文章,编辑部不再另找审稿人审查,优先在最近一期发表。②国家自然科学基金资助项目,部、省、市级科研基金资助项目的文章,以及特别优秀的论文,本刊可优先发表。        本刊特别欢迎论点鲜明、有独到见解、理论与实践相结合的论著性文章。内容包括实验研究、临床医学、预防医学、中医中药、妇幼保健、食品营养与食物链、实验技术、综述与讲座、环保、商检以及中西医结合的新理论、新技术、新成果等稿件。也十分欢迎短篇论著性论文。                

SCI论文投稿全程模板实例

时间:2024-03-22 09:31:25

SCI论文投稿全程模板主要包括以下几个部分:投稿信(Cover Letter)、论文正文、作者信息和致谢等。下面将详细介绍这些部分,并给出实例说明。

一、投稿信(Cover Letter)

投稿信是向编辑介绍论文内容和作者情况的重要文件,也是论文投稿过程中必不可少的一部分。在投稿信中,作者需要简要介绍论文的研究背景、目的、方法、结果和结论,同时说明论文的创新性和重要性。此外,作者还需要提供自己的联系方式和作者简介等信息。

以下是一个投稿信的实例:

Dear Editor,

We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.

We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.

Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.

Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.

Sincerely,

[Your Name]
[Your Affiliation]
[Your Email Address]

二、论文正文

论文正文是SCI论文投稿的核心部分,包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时,作者需要遵循学术规范和论文写作要求,确保论文内容准确、清晰、有条理。

以下是一个论文正文的实例(仅包含部分部分):

Title: The effect of XXX on XXX in a mouse model of XXX

Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.

Keywords: XXX; XXX; Mouse model; Therapeutic agent

Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.

Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.

Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).

Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.

Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.

(注:以上实例中的XXX需要根据实际情况进行替换。)

三、作者信息和致谢

在论文正文的最后,作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等;致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。

以下是一个作者信息和致谢的实例:

Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]

Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.